Milnacipran Continuation During Pregnancy: A Case Report with 3-Year Pediatric Follow-up

A 2026 case report by Maximilian Preiss details the treatment of a 31-year-old patient with severe PTSD and psychotic depression during pregnancy. The report describes a single case where milnacipran was used, discontinued, and then re-established, with follow-up of the child to age 3. The dataset is a 648.9 KB PDF document shared under a CC-BY-4.0 license on figshare.

Use Cases

• Analyze treatment decision-making for psychiatric medication during pregnancy based on the detailed case narrative.
• Study neonatal and pediatric outcomes following in-utero antidepressant exposure based on the 3-year follow-up data.
• Examine the clinical course of severe post-traumatic stress disorder with psychotic features during pregnancy based on the patient history described.

Strengths

• Includes detailed longitudinal follow-up of pediatric development to 3 years of age.
• Provides specific dosage information (milnacipran 150 mg/day) and treatment timeline.
• Document is shared under a permissive CC-BY-4.0 license for reuse.

Limitations

• Dataset is a single case report (n=1), limiting statistical generalizability.
• Row count and column-level documentation are absent; data is embedded in narrative text.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare

Collection Method

Clinical case report authored by Maximilian Preiss.

Time Range

Covers a pregnancy and a 3-year pediatric follow-up period.

Freshness

Last updated 2026-04-27 05:16:21; freshness should be verified.